These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2165265)

  • 1. Causes of the urinary concentrating defect in mice with nephrogenic diabetes insipidus.
    Valtin H; Coffey AK; O'Sullivan DJ; Homma S; Dousa TP
    Physiol Bohemoslov; 1990; 39(1):103-11. PubMed ID: 2165265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High activity of low-Michaelis-Menten constant 3', 5'-cyclic adenosine monophosphate-phosphodiesterase isozymes in renal inner medulla of mice with hereditary nephrogenic diabetes insipidus.
    Takeda S; Lin CT; Morgano PG; McIntyre SJ; Dousa TP
    Endocrinology; 1991 Jul; 129(1):287-94. PubMed ID: 1647298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of intramembranous particle clusters in mice with nephrogenic diabetes insipidus.
    Coffey AK; O'Sullivan DJ; Homma S; Dousa TP; Valtin H
    Am J Physiol; 1991 Oct; 261(4 Pt 2):F640-6. PubMed ID: 1656782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular action of antidiuretic hormone in mice with inherited vasopressin-resistant urinary concentrating defects.
    Dousa TP; Valtin H
    J Clin Invest; 1974 Sep; 54(3):753-62. PubMed ID: 4368480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular action of vasopressin in medullary tubules of mice with hereditary nephrogenic diabetes insipidus.
    Jackson BA; Edwards RM; Valtin H; Dousa TP
    J Clin Invest; 1980 Jul; 66(1):110-22. PubMed ID: 6249843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cAMP-phosphodiesterase isozymes in pathogenesis of murine nephrogenic diabetes insipidus.
    Homma S; Gapstur SM; Coffey A; Valtin H; Dousa TP
    Am J Physiol; 1991 Aug; 261(2 Pt 2):F345-53. PubMed ID: 1652209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical physiology of water metabolism. Part II: Renal mechanisms for urinary concentration; diabetes insipidus.
    Weitzman RE; Kleeman CR
    West J Med; 1979 Dec; 131(6):486-515. PubMed ID: 545867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of urinary concentration in nephrogenic diabetes insipidus.
    McConnell RF; Lorentz WB; Berger M; Smith EH; Carvajal HF; Travis LB
    Pediatr Res; 1977 Jan; 11(1 Pt 1):33-6. PubMed ID: 188007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
    Verghese MW; McConnell RT; Strickland AB; Gooding RC; Stimpson SA; Yarnall DP; Taylor JD; Furdon PJ
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1313-20. PubMed ID: 7891349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of rolipram and cilostamide on renal functions and cyclic AMP release in anesthetized dogs.
    Tanahashi M; Hara S; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1533-8. PubMed ID: 10336549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
    Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
    Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts.
    Marko D; Romanakis K; Zankl H; Fürstenberger G; Steinbauer B; Eisenbrand G
    Cell Biochem Biophys; 1998; 28(2-3):75-101. PubMed ID: 9515161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epithelium.
    Bode DC; Hamel LT; Wax MB
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1286-91. PubMed ID: 8263791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oocyte maturation involves compartmentalization and opposing changes of cAMP levels in follicular somatic and germ cells: studies using selective phosphodiesterase inhibitors.
    Tsafriri A; Chun SY; Zhang R; Hsueh AJ; Conti M
    Dev Biol; 1996 Sep; 178(2):393-402. PubMed ID: 8812137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ability of phosphodiesterase IV inhibitors to suppress superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity.
    Barnette MS; Manning CD; Cieslinski LB; Burman M; Christensen SB; Torphy TJ
    J Pharmacol Exp Ther; 1995 May; 273(2):674-9. PubMed ID: 7752069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin-resistant nephrogenic diabetes insipidus. A result of amphotericin B therapy.
    Barbour GL; Straub KD; O'Neal BL; Leatherman JW
    Arch Intern Med; 1979 Jan; 139(1):86-8. PubMed ID: 760689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of indolidan- and rolipram-sensitive cyclic nucleotide phosphodiesterases in canine and human cardiac microsomal fractions.
    Lugnier C; Muller B; Le Bec A; Beaudry C; Rousseau E
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1142-51. PubMed ID: 8389853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.